TENAZA Trademark

Trademark Overview

On Friday, May 10, 2013, a trademark application was filed for TENAZA with the United States Patent and Trademark Office. The USPTO has given the TENAZA trademark a serial number of 85928703. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 10, 2017. This trademark is owned by Glaxo Group Limited. The TENAZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
tenaza

General Information

Serial Number85928703
Word MarkTENAZA
Filing DateFriday, May 10, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 10, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 15, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe English translation of "TENAZA" in the mark is "pincers".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 3, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, April 10, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 10, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 16, 2016EXTENSION 4 GRANTED
Monday, August 15, 2016EXTENSION 4 FILED
Monday, August 15, 2016TEAS EXTENSION RECEIVED
Tuesday, March 22, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2016EXTENSION 3 GRANTED
Thursday, February 11, 2016EXTENSION 3 FILED
Friday, March 18, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 11, 2016TEAS EXTENSION RECEIVED
Tuesday, August 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 17, 2015EXTENSION 2 GRANTED
Wednesday, July 29, 2015EXTENSION 2 FILED
Friday, August 14, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 29, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 4, 2015EXTENSION 1 GRANTED
Wednesday, March 4, 2015EXTENSION 1 FILED
Wednesday, March 4, 2015TEAS EXTENSION RECEIVED
Tuesday, September 9, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 15, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 15, 2014PUBLISHED FOR OPPOSITION
Wednesday, June 25, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 9, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, June 8, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 3, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 3, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 20, 2014ASSIGNED TO LIE
Wednesday, May 7, 2014TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, January 26, 2014NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, January 26, 2014FINAL REFUSAL E-MAILED
Sunday, January 26, 2014FINAL REFUSAL WRITTEN
Friday, January 24, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 24, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 24, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 27, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 27, 2013NON-FINAL ACTION E-MAILED
Tuesday, August 27, 2013NON-FINAL ACTION WRITTEN
Tuesday, August 27, 2013REMOVED FROM TEAS PLUS
Wednesday, August 21, 2013ASSIGNED TO EXAMINER
Friday, May 17, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 14, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

tenaza pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological